Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kenneth Lasseter"'
Autor:
Jesse C. Nussbaum, Azher Hussain, K. Chris Min, Thomas C. Marbury, Kenneth Lasseter, S. Aubrey Stoch, Marian Iwamoto
Publikováno v:
The Journal of Clinical Pharmacology. 62:1435-1444
Gefapixant, a P2X3 receptor antagonist, has demonstrated efficacy in patients with refractory or unexplained chronic cough. We investigated the effect of renal impairment (RI) on the pharmacokinetics (PK) of gefapixant 50 mg in an open-label, single-
Autor:
Ying Jun, Cao, Taiji, Sawamoto, Udaya, Valluri, Kathy, Cho, Michaelene, Lewand, Suzanne, Swan, Kenneth, Lasseter, Mark, Matson, John, Holman, James, Keirns, Tong, Zhu
Publikováno v:
Clinical pharmacology in drug development. 5(6)
Two randomized, double-blind, placebo-controlled studies are reported that had the objective to evaluate the pharmacokinetics, pharmacodynamics, and safety of ASP015K (peficitinib), a Janus kinase (JAK) inhibitor, in healthy subjects. The single-dose